StemCore is a state-of-the-art, not-for-profit core facility offering comprehensive pluripotent stem cell (ESC and iPSC) and transgenic cell line generation and supply. StemCore offers a wide range of services to biologists interested in human and animal disease modelling, and using genome-edited stem cell-derived models for a wide range of tasks, from the generation of reagents for functional genomics to fluorescent reporter-aided studies on cellular functions. These services include the provision of human pluripotent stem cell lines (including our own NIH-listed and extensively-studied MEL family of human embryonic stem cell lines), off-the-shelf and custom-generated (using the latest reprogramming methods) induced pluripotent stem cells (iPSCs), and hPSCs genetically engineered, using CRISPR/Cas9 and similar approaches, to produce a wide range of transgenic human pluripotent stem cell tools, genotyping, mycoplasma detection, teratoma, karyotyping, and other assays.
At StemCore, we believe in the potential of regenerative medicine, and in giving academic research the best support it can get. Because together, we can work towards the better understanding and eradication of degenerative diseases. Our activity has long been generously supported by Bioplatforms Australia through funding from the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) scheme, and is now also supported by additional funding from the Queensland Government and the University of Queensland.
We are currently working on bringing the latest technologies and tools for the rapidly-evolving field of human cell functional genomics to researchers across Australia and around the globe.
Human Functional Genomics and Stem Cells